Summary
The product Anavar 10 mg, manufactured by Pharmaqo, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number MFG DATE: 02-2021, was submitted by eupharmago@protonmail.com and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxandrolone, with a concentration of 10.79 mg per tablet, exceeding the labeled claim of 10 mg by 7.9%.
The testing process was conducted on 9 February 2024. While the results indicate slight overdosing, it is essential to scrutinize reseller-submitted samples to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: mrp@vitamins.to
- Product Name: Anavar 10 mg
- Active Ingredient: Oxandrolone
- Batch Number: MFG DATE: 02-2021
- Expiration Date: Not provided
- Delivery Method: Oral tablet
Sample Acquisition and Testing
- Task Number: #38410
- Testing Ordered: 30 January 2024
- Sample Received: 8 February 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Eupharmaqo (Reseller)
- Analysis Paid For By:Â Eupharmaqo (Reseller)
Testing Results
- Specification: 10 mg/tab (as stated on the label)
- Measured Concentration: 10.79 mg/tab
- Accuracy: 107.9% (7.9% above the label claim)
- Variance: +7.9
Verification Details
- Verification URL: https://janoshik.com/tests/38410_6298EBP3FMIR
Evaluation of Reseller-Submitted Testing
This analysis highlights slight overdosing of the tested product, which warrants careful evaluation due to its submission and funding by the reseller eupharmago@protonmail.com. Reseller-submitted testing may involve inherent biases, as they may select specific batches for analysis. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Anavar 10 mg is slightly overdosed, with a measured concentration of 10.79 mg per tablet. This result reflects a minor deviation from the labeled claim and underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
